- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · May 14, 2026 | 969.83K sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 2M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 2M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2025 | 2M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2025 | 2M sh |
| Operating Cash Flow | Q3 2026 · Mar 31, 2026 | $159.41K |
| Operating Cash Flow | Q3 2026 · Mar 31, 2025 | $323.12K |
| Long Term Debt | Q3 2026 · Mar 31, 2026 | $118.42K |
| Cash And Equivalents | Q3 2026 · Mar 31, 2026 | $84.99K |
| Cash And Equivalents | Q3 2026 · Jun 30, 2025 | $47.44K |
| Stockholders Equity | Q3 2026 · Mar 31, 2026 | $657.17K |
| Stockholders Equity | Q3 2026 · Dec 31, 2025 | $766.64K |
| Stockholders Equity | Q3 2026 · Jun 30, 2025 | $697.81K |
| Stockholders Equity | Q3 2026 · Mar 31, 2025 | $818.24K |
| Stockholders Equity | Q3 2026 · Dec 31, 2024 | $922.95K |
| Stockholders Equity | Q3 2026 · Jun 30, 2024 | $804.35K |
| Current Liabilities | Q3 2026 · Mar 31, 2026 | $317.43K |
| Current Liabilities | Q3 2026 · Jun 30, 2025 | $332.8K |
| Total Liabilities | Q3 2026 · Mar 31, 2026 | $680.18K |
| Total Liabilities | Q3 2026 · Jun 30, 2025 | $785.55K |
| Current Assets | Q3 2026 · Mar 31, 2026 | $707.18K |
| Current Assets | Q3 2026 · Jun 30, 2025 | $748.25K |
| Total Assets | Q3 2026 · Mar 31, 2026 | $1.34M |
| Total Assets | Q3 2026 · Jun 30, 2025 | $1.48M |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | −$0.15 |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | −$0.14 |
| Eps Diluted | Q3 2026 · Mar 31, 2025 | −$0.14 |
| Eps Diluted | Q3 2026 · Mar 31, 2025 | −$0.08 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | −$0.15 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | −$0.14 |
| Eps Basic | Q3 2026 · Mar 31, 2025 | −$0.14 |
| Eps Basic | Q3 2026 · Mar 31, 2025 | −$0.08 |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $176.5K |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $549.46K |
| Sga Expense | Q3 2026 · Mar 31, 2025 | $150.61K |
| Sga Expense | Q3 2026 · Mar 31, 2025 | $534.32K |
| Net Income | Q3 2026 · Mar 31, 2026 | −$109.47K |
| Net Income | Q3 2026 · Mar 31, 2026 | −$40.64K |
| Net Income | Q3 2026 · Mar 31, 2025 | −$104.71K |
| Net Income | Q3 2026 · Mar 31, 2025 | $13.89K |
| Operating Income | Q3 2026 · Mar 31, 2026 | −$109.76K |
| Operating Income | Q3 2026 · Mar 31, 2026 | −$27.55K |
| Operating Income | Q3 2026 · Mar 31, 2025 | −$138.13K |
| Operating Income | Q3 2026 · Mar 31, 2025 | $28.82K |
| Gross Profit | Q3 2026 · Mar 31, 2026 | $158.04K |
| Gross Profit | Q3 2026 · Mar 31, 2026 | $789.88K |
| Gross Profit | Q3 2026 · Mar 31, 2025 | $76.11K |
| Gross Profit | Q3 2026 · Mar 31, 2025 | $836.29K |
| Cost Of Revenue | Q3 2026 · Mar 31, 2026 | $269.03K |
| Cost Of Revenue | Q3 2026 · Mar 31, 2026 | $1.52M |
| Cost Of Revenue | Q3 2026 · Mar 31, 2025 | $232.36K |
| Cost Of Revenue | Q3 2026 · Mar 31, 2025 | $1.92M |
| Revenue | Q3 2026 · Mar 31, 2026 | $427.06K |
| Revenue | Q3 2026 · Mar 31, 2026 | $2.31M |
| Revenue | Q3 2026 · Mar 31, 2025 | $308.46K |
| Revenue | Q3 2026 · Mar 31, 2025 | $2.75M |
| Capex | Q3 2026 · Mar 31, 2025 | $77.5K |